Is LUV Stock a Buy, Sell or Hold?
Southwest Airlines (NYSE:LUV) is one of America’s major air transportation…
Sell
40
RAFA Quote, Financials, Valuation and Earnings
Last price:
$0.1300
Seasonality move
:
176.06%
Day range:
$0.1323 - $0.1323
52-week range:
$0.0330 - $0.1790
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
--
Avg. volume:
23.9K
1-year change:
-5.5%
Market cap:
$11.1M
Revenue:
--
EPS (TTM):
--
Earnings Data
Next earnings date for RAFA
May 15
2025
Most recent earnings per share
--
Missed by --
(Apr 3/2025)
Consensus Estimate
--
(Apr 3/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
RAFA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|
Rafarma Pharmaceuticals Earnings Questions
-
How Much did Rafarma Pharmaceuticals Generate in Revenue Last Quarter?
Rafarma Pharmaceuticals reported -- worth of top line sales in its most recent quarter.
-
Did Rafarma Pharmaceuticals Beat Earnings Last Quarter?
Rafarma Pharmaceuticals announced earnings per share of -- which represents a miss of analyst forecast a -- per share.
-
Is Rafarma Pharmaceuticals Profitable?
Rafarma Pharmaceuticals reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Rafarma Pharmaceuticals EPS Next Year?
Rafarma Pharmaceuticals's earnings are forecast to grow from -- per share to -- per share next year representing an increase of --.
-
When is Rafarma Pharmaceuticals's Earnings Date?
Rafarma Pharmaceuticals's next earnings date is May 15, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Should I Buy Alcoa Stock?
Alcoa (AA) finds itself in an interesting position in early…
Where Will Nu Holdings Stock Be in 2030?
Despite fast growth, high profitability and an extraordinary runway ahead,…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Sell
47
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
44
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Sell
43
MNPR alert for Apr 3
Monopar Therapeutics [MNPR] is down 7.22% over the past day.
Buy
75
BKTI alert for Apr 3
BK Technologies [BKTI] is down 9.62% over the past day.
Sell
34
SWTX alert for Apr 3
SpringWorks Therapeutics [SWTX] is down 5.87% over the past day.
